1y6k › Citations

Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.

Yoon SI, Jones BC, Logsdon NJ, Walter MR
Structure 13 551-64 (2005)
Related entries: 1y6m, 1y6n

Cited: 66 times
EuropePMC logo PMID: 15837194

Abstract

Human IL-10 (hIL-10) is a cytokine that modulates diverse immune responses. The Epstein-Barr virus (EBV) genome contains an IL-10 homolog (vIL-10) that shares high sequence and structural similarity with hIL-10. Although vIL-10 suppresses inflammatory responses like hIL-10, it cannot activate many other immunostimulatory functions performed by the cellular cytokine. These functional differences have been correlated with the approximately 1000-fold lower affinity of vIL-10, compared to hIL-10, for the IL-10R1 receptor chain. To define the structural basis for these observations, crystal structures of vIL-10 and a vIL-10 point mutant were determined bound to the soluble IL-10R1 receptor fragment (sIL-10R1) at 2.8 and 2.7 A resolution, respectively. The structures reveal that subtle changes in the conformation and dynamics of the vIL-10 AB and CD loops and an orientation change of vIL-10 on sIL-10R1 are the main factors responsible for vIL-10's reduced affinity for sIL-10R1 and its distinct biological profile.

Reviews - 1y6k mentioned but not cited (2)

  1. Structural analysis of cytokines comprising the IL-10 family. Zdanov A. Cytokine Growth Factor Rev 21 325-330 (2010)
  2. Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors. Cai K, Zhang X, Bai XC. Chem Rev 122 13952-13988 (2022)

Articles - 1y6k mentioned but not cited (16)

  1. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. N Engl J Med 361 2033-2045 (2009)
  2. Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10. Saxton RA, Saxton RA, Tsutsumi N, Su LL, Abhiraman GC, Mohan K, Henneberg LT, Aduri NG, Gati C, Garcia KC. Science 371 eabc8433 (2021)
  3. Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O'Brien SJ, SOCA Research Group. J Infect Dis 202 606-613 (2010)
  4. Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus. Logsdon NJ, Eberhardt MK, Allen CE, Barry PA, Walter MR. PLoS One 6 e28127 (2011)
  5. Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy. Künze G, Köhling S, Vogel A, Rademann J, Huster D. J Biol Chem 291 3100-3113 (2016)
  6. Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Guven-Maiorov E, Acuner-Ozbabacan SE, Keskin O, Gursoy A, Nussinov R. Cancers (Basel) 6 663-683 (2014)
  7. Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking. Zhang Y, Li X, Guo C, Dong J, Liao L. BMC Complement Med Ther 20 229 (2020)
  8. Computational Protein Phenotype Characterization of IL10RA Mutations Causative to Early Onset Inflammatory Bowel Disease (IBD). Al-Abbasi FA, Mohammed K, Sadath S, Banaganapalli B, Nasser K, Shaik NA. Front Genet 9 146 (2018)
  9. Bacterial expression of a designed single-chain IL-10 prevents severe lung inflammation. Montero-Blay A, Blanco JD, Rodriguez-Arce I, Lastrucci C, Piñero-Lambea C, Lluch-Senar M, Serrano L. Mol Syst Biol 19 e11037 (2023)
  10. Homology Modeling and Optimized Expression of Truncated IK Protein, tIK, as an Anti-Inflammatory Peptide. Song Y, Kim M, Kim Y. Molecules 25 E4358 (2020)
  11. ProteinFishing: a protein complex generator within the ModelX toolsuite. Cianferoni D, Radusky LG, Head SA, Serrano L, Delgado J. Bioinformatics 36 4208-4210 (2020)
  12. Molecular modelling of the HCMV IL-10 protein isoforms and analysis of their interaction with the human IL-10 receptor. Pantaleão SQ, Camillo LMB, Neves TC, Menezes IG, Stangherlin LM, Batista HBCR, Poole E, Nevels M, Philot EA, Scott AL, Carlan da Silva MC. PLoS One 17 e0277953 (2022)
  13. Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications. Aschenbrenner D, Ye Z, Zhou Y, Hu W, Brooks I, Williams I, Capitani M, Gartner L, Kotlarz D, Snapper SB, Klein C, Muise AM, Marsden BD, Huang Y, Uhlig HH. J Clin Immunol 43 495-511 (2023)
  14. Phytochemical mediated modulation of COX-3 and NFκB for the management and treatment of arthritis. Biswas D, Somkuwar BG, Borah JC, Varadwaj PK, Gupta S, Khan ZA, Mondal G, Chattoraj A, Deb L. Sci Rep 13 13612 (2023)
  15. Suppressive Effects of a Truncated Inhibitor K562 Protein-Derived Peptide on Two Proinflammatory Cytokines, IL-17 and TNF-α. Hwang JT, Yu JW, Nam HJ, Song SK, Sung WY, Kim Y, Cho JH. J Microbiol Biotechnol 30 1810-1818 (2020)
  16. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation. Chang CC, Liu CD, Pan SF, Huang WH, Peng CW, Hsu HJ. Ci Ji Yi Xue Za Zhi 32 245-253 (2020)


Reviews citing this publication (12)

  1. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. Cytokine Growth Factor Rev 54 62-75 (2020)
  2. IL-10: A Multifunctional Cytokine in Viral Infections. Rojas JM, Avia M, Martín V, Sevilla N. J Immunol Res 2017 6104054 (2017)
  3. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A. J Virol 83 9618-9629 (2009)
  4. Inflamed gut mucosa: downstream of interleukin-10. Paul G, Khare V, Gasche C. Eur J Clin Invest 42 95-109 (2012)
  5. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Walter MR. Curr Top Microbiol Immunol 380 191-212 (2014)
  6. IL-10 encoded by viruses: a remarkable example of independent acquisition of a cellular gene by viruses and its subsequent evolution in the viral genome. Ouyang P, Rakus K, van Beurden SJ, Westphal AH, Davison AJ, Gatherer D, Vanderplasschen AF. J Gen Virol 95 245-262 (2014)
  7. Survey of the year 2005 commercial optical biosensor literature. Rich RL, Myszka DG. J Mol Recognit 19 478-534 (2006)
  8. Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Felix J, Savvides SN. Nat Rev Immunol 17 112-129 (2017)
  9. Cytokine homologs of human gammaherpesviruses. Sin SH, Dittmer DP. J Interferon Cytokine Res 32 53-59 (2012)
  10. Proteins: form and function. Sleator RD. Bioeng Bugs 3 80-85 (2012)
  11. An overview of the processes shaping protein evolution. Sleator RD. Sci Prog 93 1-6 (2010)
  12. Mapping Determinants of Cytokine Signaling via Protein Engineering. Gorby C, Martinez-Fabregas J, Wilmes S, Moraga I. Front Immunol 9 2143 (2018)

Articles citing this publication (36)

  1. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Jaitin DA, Roisman LC, Jaks E, Gavutis M, Piehler J, Van der Heyden J, Uze G, Schreiber G. Mol Cell Biol 26 1888-1897 (2006)
  2. Analyzing and visualizing residue networks of protein structures. Doncheva NT, Klein K, Domingues FS, Albrecht M. Trends Biochem Sci 36 179-182 (2011)
  3. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Jones BC, Logsdon NJ, Walter MR. Structure 16 1333-1344 (2008)
  4. Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. Wilmes S, Beutel O, Li Z, Francois-Newton V, Richter CP, Janning D, Kroll C, Hanhart P, Hötte K, You C, Uzé G, Pellegrini S, Piehler J. J Cell Biol 209 579-593 (2015)
  5. Structure and mechanism of receptor sharing by the IL-10R2 common chain. Yoon SI, Jones BC, Logsdon NJ, Harris BD, Deshpande A, Radaeva S, Halloran BA, Gao B, Walter MR. Structure 18 638-648 (2010)
  6. Crystal structure of human interferon-λ1 in complex with its high-affinity receptor interferon-λR1. Miknis ZJ, Magracheva E, Li W, Zdanov A, Kotenko SV, Wlodawer A. J Mol Biol 404 650-664 (2010)
  7. Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency. Moraga I, Richter D, Wilmes S, Winkelmann H, Jude K, Thomas C, Suhoski MM, Engleman EG, Piehler J, Garcia KC. Sci Signal 8 ra114 (2015)
  8. Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1. Elegheert J, Bracke N, Pouliot P, Gutsche I, Shkumatov AV, Tarbouriech N, Verstraete K, Bekaert A, Burmeister WP, Svergun DI, Lambrecht BN, Vergauwen B, Savvides SN. Nat Struct Mol Biol 19 938-947 (2012)
  9. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Lazarus JJ, Kay MA, McCarter AL, Wooten RM. Infect Immun 76 1153-1162 (2008)
  10. Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency. Hughes C, Sette A, Seed M, D'Acquisto F, Manzo A, Vincent TL, Lim NH, Nissim A. Arthritis Res Ther 16 R151 (2014)
  11. A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Hayes CE, Donald Acheson E. Med Hypotheses 71 85-90 (2008)
  12. Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco. Bortesi L, Rossato M, Schuster F, Raven N, Stadlmann J, Avesani L, Falorni A, Bazzoni F, Bock R, Schillberg S, Pezzotti M. BMC Biotechnol 9 22 (2009)
  13. Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Gorby C, Sotolongo Bellón J, Wilmes S, Warda W, Pohler E, Fyfe PK, Cozzani A, Ferrand C, Walter MR, Mitra S, Piehler J, Moraga I. Sci Signal 13 eabc0653 (2020)
  14. Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1. Gruber SG, Gloria Luciani M, Grundtner P, Zdanov A, Gasche C. Eur J Immunol 38 3365-3375 (2008)
  15. Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties. Yoon SI, Jones BC, Logsdon NJ, Harris BD, Kuruganti S, Walter MR. J Biol Chem 287 26586-26595 (2012)
  16. The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates. Kanai K, Satoh Y, Yamanaka H, Kawaguchi A, Horie K, Sugata K, Hoshikawa Y, Sata T, Sairenji T. Virus Genes 35 563-569 (2007)
  17. Oncoviruses Can Drive Cancer by Rewiring Signaling Pathways Through Interface Mimicry. Guven-Maiorov E, Tsai CJ, Nussinov R. Front Oncol 9 1236 (2019)
  18. Peptide matching between Epstein-Barr virus and human proteins. Capone G, Calabrò M, Lucchese G, Fasano C, Girardi B, Polimeno L, Kanduc D. Pathog Dis 69 205-212 (2013)
  19. Characterization of specific antibodies against cytomegalovirus (CMV)-encoded interleukin 10 produced by 28% of CMV-seropositive blood donors. de Lemos Rieper C, Galle P, Pedersen BK, Hansen MB. J Gen Virol 92 1508-1518 (2011)
  20. Domain-domain interactions underlying herpesvirus-human protein-protein interaction networks. Itzhaki Z. PLoS One 6 e21724 (2011)
  21. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity. Ausar SF, Zhu S, Duprez J, Cohen M, Bertrand T, Steier V, Wilson DJ, Li S, Sheung A, Brookes RH, Pedyczak A, Rak A, Andrew James D. Commun Biol 3 427 (2020)
  22. QTY Code-designed Water-soluble Fc-fusion Cytokine Receptors Bind to their Respective Ligands. Hao S, Jin D, Zhang S, Qing R. QRB Discov 1 e4 (2020)
  23. Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes. Irons RD, Le AT. Chem Biol Interact 172 81-92 (2008)
  24. Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli. Yoon SI, Walter MR. Protein Expr Purif 53 132-137 (2007)
  25. The next generation of similarity measures that fully explore the semantics in biomedical ontologies. Couto FM, Pinto HS. J Bioinform Comput Biol 11 1371001 (2013)
  26. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B. J Med Virol 83 644-650 (2011)
  27. Interleukin 2 Secretion by T Cells for Detection of Biologically Active Staphylococcal Enterotoxin Type E. Rasooly R, Do P, Hernlem BJ. J Food Prot 80 1857-1862 (2017)
  28. Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma. Han L, Sun L, Zhao Z, Chao Y, Sun Z, Li H, Luo B. Arch Virol 160 441-445 (2015)
  29. Binding of interferon reduces the force of unfolding for interferon receptor 1. Chuartzman SG, Nevo R, Waichman S, Shental D, Piehler J, Levy Y, Reich Z, Kapon R. PLoS One 12 e0175413 (2017)
  30. Secretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter construct. Förster S, Brandt M, Mottok DS, Zschüttig A, Zimmermann K, Blattner FR, Gunzer F, Pöhlmann C. BMC Biotechnol 13 82 (2013)
  31. Identifying functionally important cis-peptide containing segments in proteins and their utility in molecular function annotation. Das S, Ramakumar S, Pal D. FEBS J 281 5602-5621 (2014)
  32. Parapoxvirus Interleukin-10 Homologues Vary in Their Receptor Binding, Anti-Inflammatory, and Stimulatory Activities. Naqash A, Stuart G, Kemp R, Wise L. Pathogens 11 507 (2022)
  33. A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics. Chang CC, Yang CH, Chuang CH, Jiang SJ, Hwang YM, Liou JW, Hsu HJ. Commun Chem 6 278 (2023)
  34. A workflow for in silico design of hIL-10 and ebvIL-10 inhibitors using well-known miniprotein scaffolds. Dueñas S, Aguila SA, Pimienta G. J Mol Model 23 118 (2017)
  35. Class II cytokine common receptors: something old, something new. Hinck AP. Structure 18 551-552 (2010)
  36. Purification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex. Logsdon NJ, Allen CE, Rajashankar KR, Walter MR. Acta Crystallogr Sect F Struct Biol Cryst Commun 68 89-92 (2012)


Quick links